citrulline and Muscle Weakness

citrulline has been researched along with Muscle Weakness in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Caldow, MK; Chee, A; Ham, DJ; Kennedy, TL; Koopman, R; Lynch, GS	1
Chrétien, D; Cormier-Daire, V; de Lonlay, P; Munnich, A; Parfait, B; Rabier, D; Rötig, A; Rustin, P; Saudubray, JM; von Kleist-Retzow, JC	1

Other Studies

2 other study(ies) available for citrulline and Muscle Weakness

Article	Year
Citrulline does not prevent skeletal muscle wasting or weakness in limb-casted mice. The Journal of nutrition, 2015, Volume: 145, Issue:5 Topics: Animals; Autophagy; Biomarkers; Citrulline; Dietary Supplements; Disease Models, Animal; Fracture Fixation; Gene Expression Regulation; Hindlimb; Male; Membrane Proteins; Mice, Inbred C57BL; Microtubule-Associated Proteins; Mitochondrial Proteins; Muscle Proteins; Muscle Weakness; Muscle, Skeletal; Muscular Atrophy; Nitric Oxide Synthase Type II; Protein Isoforms; Restraint, Physical	2015
The neurogenic weakness, ataxia and retinitis pigmentosa (NARP) syndrome mtDNA mutation (T8993G) triggers muscle ATPase deficiency and hypocitrullinaemia. European journal of pediatrics, 1999, Volume: 158, Issue:1 Topics: Adenosine Triphosphatases; Ataxia; Citrulline; DNA, Mitochondrial; Female; Humans; Infant; Infant, Newborn; Intestine, Small; Male; Metabolism, Inborn Errors; Muscle Weakness; Mutation; Oxidative Phosphorylation; Pedigree; Retinitis Pigmentosa; Syndrome	1999

Article

Year

Citrulline does not prevent skeletal muscle wasting or weakness in limb-casted mice.

The Journal of nutrition, 2015, Volume: 145, Issue:5

Topics: Animals; Autophagy; Biomarkers; Citrulline; Dietary Supplements; Disease Models, Animal; Fracture Fixation; Gene Expression Regulation; Hindlimb; Male; Membrane Proteins; Mice, Inbred C57BL; Microtubule-Associated Proteins; Mitochondrial Proteins; Muscle Proteins; Muscle Weakness; Muscle, Skeletal; Muscular Atrophy; Nitric Oxide Synthase Type II; Protein Isoforms; Restraint, Physical

2015

The neurogenic weakness, ataxia and retinitis pigmentosa (NARP) syndrome mtDNA mutation (T8993G) triggers muscle ATPase deficiency and hypocitrullinaemia.

European journal of pediatrics, 1999, Volume: 158, Issue:1

Topics: Adenosine Triphosphatases; Ataxia; Citrulline; DNA, Mitochondrial; Female; Humans; Infant; Infant, Newborn; Intestine, Small; Male; Metabolism, Inborn Errors; Muscle Weakness; Mutation; Oxidative Phosphorylation; Pedigree; Retinitis Pigmentosa; Syndrome

1999